A detailed history of Ground Swell Capital, LLC transactions in Equillium, Inc. stock. As of the latest transaction made, Ground Swell Capital, LLC holds 16,550 shares of EQ stock, worth $15,391. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,550
Holding current value
$15,391
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

BUY
$0.29 - $0.5 $4,799 - $8,275
16,550 New
16,550 $5,000
Q1 2024

May 13, 2024

BUY
$0.73 - $3.0 $8,346 - $34,299
11,433 New
11,433 $26,000

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $31.9M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Ground Swell Capital, LLC Portfolio

Follow Ground Swell Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ground Swell Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ground Swell Capital, LLC with notifications on news.